CrushSCI.com
98.2Average days
93Median days
44Fastest days
148Longest days
7622025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

68 days

Automated expansion of iPSCs enables scalable extracellular vesicle production with anti-senescence bioactivity

Authors
Toshihiko Nambara; Tammee M. Parsons; Ana-Caroline Raulin; Angelica Gaona; Bhaskar Roy; Takahisa KanekiyoShow moreShow less
Affiliations
Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USAShow moreShow less
Source PDF DOI Publisher page
81 days

Higher yields of Vγ9Vδ2 T cells from peripheral blood than umbilical cord blood via interleukin-12 and interleukin-18

Authors
Shih-Feng Cho; Wan-En Liao; Yi-Chang Liu; Te-Fu Chan; Shian-Ren Lin; Chia-Chun Tu; Ya-Fang Cheng; Chih-Hao Fang; Yuan-Yuan Huang; Shiu-Lan Wang; Wan-Yu Lai; Yee Chao; Li-Tzong Chen; Jan-Mou LeeShow moreShow less
Affiliations
Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 80738, Taiwan; FullHope Biomedical Co. Ltd., New Taipei City, Taiwan; Department of Gynecology and Obstetrics, Kaohsiung Medical University Hospital, Kaohsiung, 80756, Taiwan; Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, and Center for Cancer Research and College of Medicine, Kaohsiung Medical University, Kaohsiung, 80738, TaiwanShow moreShow less
Source PDF DOI Publisher page
148 days

Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease

Authors
Makoto Murata; Seitaro Terakura; Junya Kanda; Naoyuki Uchida; Satoshi Yoshihara; Takahiro Fukuda; Keisuke Kataoka; Atsushi Wake; Noriko Doki; Shuichi Ota; Maho Sato; Masahito Tokunaga; Yasuo Mori; Hirohisa Nakamae; Moeko Hino; Makoto Onizuka; Ken Tabuchi; Yoshiko Atsuta; Takanori TeshimaShow moreShow less
Affiliations
Department of Hematology, Shiga University of Medical Science, Otsu, Japan; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Hematology, Kyoto University, Kyoto, Japan; Department of Hematology, Toranomon Hospital, Tokyo, Japan; Department of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan; Department of Hematology, Toranomon Hospital, Kajigaya Kawasaki, Tokyo, Japan; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan; Department of Hematology/Oncology, Osaka Women’s and Children’s Hospital, Izumi, Japan; Department of Hematology, Imamura General Hospital, Kagoshima, Japan; Hematology, Oncology & Cardiovascular medicine, Kyushu University Hospital, Fukuoka, Japan; Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan; Department of Pediatrics, School of Medicine, Chiba University, Chiba, Japan; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan; Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, JapanShow moreShow less
Source PDF DOI Publisher page
148 days

MSC-delivered high-affinity variants of soluble PD1 lead to tumor regression

Authors
Serap Gokcen; Tianyuan Chu; Phoebe Elizabeth Blair; Natalia Magdalena Krajewska; Greg Nicholas Brooke; Stuart Rushworth; Philippe Pierre Laissue; Ralf Michael Zwacka; Andrea MohrShow moreShow less
Affiliations
School of Life Sciences, Protein Structure and Mechanisms of Disease Group, Cancer and Stem Cell Biology Group, University of Essex, Colchester, UK; School of Life Sciences, Protein Structure and Mechanisms of Disease Group, Molecular Oncology Laboratory, University of Essex, Colchester, UK; Metabolic Health Research Centre, Norwich Medical School, University of East Anglia, Norwich, UK; School of Life Sciences, Bioimaging Facility, University of Essex, Colchester, UKShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.